DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).
Andes virus (ANDV) is the predominant cause of hantavirus pulmonary syndrome (HPS) in South America and the only hantavirus known to be transmitted person-to-person. There are no vaccines, prophylactics, or therapeutics to prevent or treat this highly pathogenic disease (case-fatality 35-40%). Infec...
Main Authors: | Rebecca Brocato, Matthew Josleyn, John Ballantyne, Pablo Vial, Jay W Hooper |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3338771?pdf=render |
Similar Items
-
Progress on the Prevention and Treatment of Hantavirus Disease
by: Rebecca L. Brocato, et al.
Published: (2019-07-01) -
Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.
by: Nicole Haese, et al.
Published: (2015-01-01) -
Seroprevalence of Hantavirus among Manual Cane Cutters and Epidemiological Aspects of HPS in Central Brazil
by: Renata Malachini Maia, et al.
Published: (2023-11-01) -
Gastrointestinal Tract As Entry Route for Hantavirus Infection
by: Peter T. Witkowski, et al.
Published: (2017-09-01) -
Hemodynamic and Pulmonary Permeability Characterization of Hantavirus Cardiopulmonary Syndrome by Transpulmonary Thermodilution
by: René López, et al.
Published: (2019-09-01)